Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial.
Saved in:
| Title: | Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial. |
|---|---|
| Authors: | Galsky MD; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. matthew.galsky@mssm.edu.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. matthew.galsky@mssm.edu., Daneshmand S; Department of Urology, Keck School of Medicine of USC, Norris Comprehensive Cancer Center, Los Angeles, CA, USA., Izadmehr S; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Gonzalez-Kozlova E; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Chan KG; Department of Urology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Lewis S; Department of Radiology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Achkar BE; Department of Radiology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Dorff TB; Department of Medical Oncology & Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Cetnar JP; Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR, USA., Neil BO; Department of Urology, University of Utah, Salt Lake City, UT, USA., D'Souza A; Division of Hematology and Medical Oncology, Keck School of Medicine of USC, Norris Comprehensive Cancer Center, Los Angeles, CA, USA., Mamtani R; Division of Hematology and Medical Oncology, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA, USA., Kyriakopoulos C; Division of Hematology and Medical Oncology, University of Wisconsin Carbone Cancer Center, Madison, WI, USA., Jun T; Genentech, South San Francisco, CA, USA.; Formerly with the Icahn School of Medicine at Mount Sinai, New York, NY, USA., Gogerly-Moragoda M; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Brody R; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Xie H; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Nie K; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Kelly G; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Horowitz A; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Kinoshita Y; Department of Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Ellis E; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Nose Y; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Ioannou G; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Cabal R; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Del Valle DM; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Haines GK; Department of Pathology, Molecular and Cell-based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Wang L; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Gene Dx, Stamford, CT, USA., Mouw KW; Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA., Samstein RM; Department of Radiation Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Mehrazin R; Department of Urology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Bhardwaj N; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Yu M; Department of Biostatistics and Medical Informatics, University of Wisconsin Carbone Cancer Center, Madison, WI, USA., Zhao Q; Department of Biostatistics and Medical Informatics, University of Wisconsin Carbone Cancer Center, Madison, WI, USA., Kim-Schulze S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Sebra R; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Zhu J; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Gene Dx, Stamford, CT, USA., Gnjatic S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Sfakianos J; Department of Urology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Pal SK; Department of Medical Oncology & Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. |
| Source: | Nature medicine [Nat Med] 2024 Apr; Vol. 30 (4), pp. 1211. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38242983 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Galsky+MD%22">Galsky MD</searchLink>; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. matthew.galsky@mssm.edu.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. matthew.galsky@mssm.edu.<br /><searchLink fieldCode="AU" term="%22Daneshmand+S%22">Daneshmand S</searchLink>; Department of Urology, Keck School of Medicine of USC, Norris Comprehensive Cancer Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Izadmehr+S%22">Izadmehr S</searchLink>; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Gonzalez-Kozlova+E%22">Gonzalez-Kozlova E</searchLink>; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Chan+KG%22">Chan KG</searchLink>; Department of Urology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lewis+S%22">Lewis S</searchLink>; Department of Radiology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Achkar+BE%22">Achkar BE</searchLink>; Department of Radiology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Dorff+TB%22">Dorff TB</searchLink>; Department of Medical Oncology & Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Cetnar+JP%22">Cetnar JP</searchLink>; Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Neil+BO%22">Neil BO</searchLink>; Department of Urology, University of Utah, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22D'Souza+A%22">D'Souza A</searchLink>; Division of Hematology and Medical Oncology, Keck School of Medicine of USC, Norris Comprehensive Cancer Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Mamtani+R%22">Mamtani R</searchLink>; Division of Hematology and Medical Oncology, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Kyriakopoulos+C%22">Kyriakopoulos C</searchLink>; Division of Hematology and Medical Oncology, University of Wisconsin Carbone Cancer Center, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Jun+T%22">Jun T</searchLink>; Genentech, South San Francisco, CA, USA.; Formerly with the Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Gogerly-Moragoda+M%22">Gogerly-Moragoda M</searchLink>; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Brody+R%22">Brody R</searchLink>; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Xie+H%22">Xie H</searchLink>; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Nie+K%22">Nie K</searchLink>; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Kelly+G%22">Kelly G</searchLink>; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Horowitz+A%22">Horowitz A</searchLink>; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Kinoshita+Y%22">Kinoshita Y</searchLink>; Department of Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Ellis+E%22">Ellis E</searchLink>; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Nose+Y%22">Nose Y</searchLink>; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Ioannou+G%22">Ioannou G</searchLink>; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Cabal+R%22">Cabal R</searchLink>; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Del+Valle+DM%22">Del Valle DM</searchLink>; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Haines+GK%22">Haines GK</searchLink>; Department of Pathology, Molecular and Cell-based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Gene Dx, Stamford, CT, USA.<br /><searchLink fieldCode="AU" term="%22Mouw+KW%22">Mouw KW</searchLink>; Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Samstein+RM%22">Samstein RM</searchLink>; Department of Radiation Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Mehrazin+R%22">Mehrazin R</searchLink>; Department of Urology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Bhardwaj+N%22">Bhardwaj N</searchLink>; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Yu+M%22">Yu M</searchLink>; Department of Biostatistics and Medical Informatics, University of Wisconsin Carbone Cancer Center, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Zhao+Q%22">Zhao Q</searchLink>; Department of Biostatistics and Medical Informatics, University of Wisconsin Carbone Cancer Center, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Kim-Schulze+S%22">Kim-Schulze S</searchLink>; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Sebra+R%22">Sebra R</searchLink>; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Zhu+J%22">Zhu J</searchLink>; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Gene Dx, Stamford, CT, USA.<br /><searchLink fieldCode="AU" term="%22Gnjatic+S%22">Gnjatic S</searchLink>; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Sfakianos+J%22">Sfakianos J</searchLink>; Department of Urology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Pal+SK%22">Pal SK</searchLink>; Department of Medical Oncology & Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2024 Apr; Vol. 30 (4), pp. 1211. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38242983 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41591-024-02814-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1211 Titles: – TitleFull: Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Galsky MD – PersonEntity: Name: NameFull: Daneshmand S – PersonEntity: Name: NameFull: Izadmehr S – PersonEntity: Name: NameFull: Gonzalez-Kozlova E – PersonEntity: Name: NameFull: Chan KG – PersonEntity: Name: NameFull: Lewis S – PersonEntity: Name: NameFull: Achkar BE – PersonEntity: Name: NameFull: Dorff TB – PersonEntity: Name: NameFull: Cetnar JP – PersonEntity: Name: NameFull: Neil BO – PersonEntity: Name: NameFull: D'Souza A – PersonEntity: Name: NameFull: Mamtani R – PersonEntity: Name: NameFull: Kyriakopoulos C – PersonEntity: Name: NameFull: Jun T – PersonEntity: Name: NameFull: Gogerly-Moragoda M – PersonEntity: Name: NameFull: Brody R – PersonEntity: Name: NameFull: Xie H – PersonEntity: Name: NameFull: Nie K – PersonEntity: Name: NameFull: Kelly G – PersonEntity: Name: NameFull: Horowitz A – PersonEntity: Name: NameFull: Kinoshita Y – PersonEntity: Name: NameFull: Ellis E – PersonEntity: Name: NameFull: Nose Y – PersonEntity: Name: NameFull: Ioannou G – PersonEntity: Name: NameFull: Cabal R – PersonEntity: Name: NameFull: Del Valle DM – PersonEntity: Name: NameFull: Haines GK – PersonEntity: Name: NameFull: Wang L – PersonEntity: Name: NameFull: Mouw KW – PersonEntity: Name: NameFull: Samstein RM – PersonEntity: Name: NameFull: Mehrazin R – PersonEntity: Name: NameFull: Bhardwaj N – PersonEntity: Name: NameFull: Yu M – PersonEntity: Name: NameFull: Zhao Q – PersonEntity: Name: NameFull: Kim-Schulze S – PersonEntity: Name: NameFull: Sebra R – PersonEntity: Name: NameFull: Zhu J – PersonEntity: Name: NameFull: Gnjatic S – PersonEntity: Name: NameFull: Sfakianos J – PersonEntity: Name: NameFull: Pal SK IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2024 Apr Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1546-170X Numbering: – Type: volume Value: 30 – Type: issue Value: 4 Titles: – TitleFull: Nature medicine Type: main |
| ResultId | 1 |